MYCN and cancer: Of note, the transcript levels of the oncogene N-Myc, a recognized miR-101 target gene in cancer [20] and involved in the aggressiveness of RMS [21], were markedly reduced in miR-101-over-expressing RD cells (Additional file 3: Figure S3A), confirming a targeted effect of miR-101 forced expression also in our setting.